CEO INVESTORCONFERENCE

bio.org/CEO • #BIOCEO17

Audience Demographics

Now in its 19th year, the BIO CEO & Investor Conference is one of the largest investor conference focused on established and emerging publicly traded and select private biotech companies.

February 13-14, 2017 • The Waldorf Astoria New York

86%86% of attendees are VP or C-Level

DirectorOther VPC-level

86%

4% 10% 76% 10%

Oncology: 29%

Platform Discovery: 2%

Infectious Diseases: 2%

CNS: 13%

Other: 10%Orphan/Rare Diseases: 10%

Autoimmune Inflammation: 7%

Devices & Drug Delivery: 4%

Metabolic Diseases: 4%

Ophthalmology: 4%

Multiple: 4%

Regenerative Medicine: 3%

Cardiovascular: 3%

Gastrointestinal: 3%

Diagnostics: 2%

Breakdown by Therapeutic Focus:

Job Profile:

82%82% of all companies attending are biopharma

Companies Profile:

Attendees: 1,400+One-on-One Meetings: 2,500+Registered Investors: 650Company Presentations: 190Expert Speakers: 58

< $50M: 36%

$500M: 4%

$100M-250M: 32%

$50M-100M: 22%

$250M-500M: 6%

Breakdown by Market Cap:

bio.org/CEO

February 13-14, 2017 • The Waldorf Astoria New York

CEO INVESTORCONFERENCE

2

Past Fireside Chat Speakers

Samuel D. IsalyManaging Partner, OrbiMed Advisors

John F. Milligan, PhDPresident and Chief Operating Officer, Gilead Sciences

Christi ShawUS Country Head, President of Novartis Corporation & President of Novartis Pharmaceuticals Corporation

George A. Scangos, PhDChief Executive Officer, Biogen

Charles E. SchumerUnited States Senator for New York (D)

Event Attributes and Opportunities

▲ Experience the largest, unbiased forum where institutional investors, industry analysts, and senior biotechnology executives shape the future investment landscape of the industry.

▲ Hear Washington’s perspective on policy and other timely developments affecting the industry.

▲ Evaluate fresh investment opportunities including compatible, complementary, and competitive companies.

▲ Learn about the hottest clinical developments and industry catalysts by attending the conference’s therapeutic workshops and business roundtables.

▲ Attend fireside chats with CEOs who will share their recent company successes, what keeps the C-suite up at night, and where the industry’s leading companies are headed in 2017.

▲ Gain access to BIO One-on-One Partnering™ for scouting potential investments and deal partners, optimizing your time at the event.

▲ Unique platform for your company to highlight accomplishments and discuss upcoming milestones. Approximately 190 companies will be chosen based on a selection process evaluating a company’s pipeline and R&D activities.

▲ Get the pulse of the current and proposed investment trends in biotechnology.

▲ Network with peers, investors, and potential partners attending the conference and our exclusive receptions.

Advisory CommitteeJohn Chambers, Vice-Chairman and Head of Healthcare Investment Banking, ROTH Capital PartnersBarbara J. Dalton, PhD, Vice President, Venture Capital, Pfizer Inc.Linda S. Grais, MD, President and Chief Executive Officer, Ocera TherapeuticsBrian Hagerty, Senior Director, Head of Healthcare Capital Markets, New York Stock ExchangeNouhad Husseini, Vice President, Business Development, Regeneron Pharmaceuticals, Inc.Michael King, Managing Director and Senior Research Analyst, JMP SecuritiesJonathan Leff, Partner, Deerfield ManagementMichael Mirsky, Managing Director, Investment Banking, H.C. WainwrightTimothy P. O’Connor, PhD, Executive Vice President, The Rockefeller UniversityJason Park, Principal, Flagship VenturesDennis J. Purcell, Founder and Senior Advisor, Aisling CapitalCarlo Rizzuto, PhD, Partner, Versant VenturesMatthew Roden, PhD, Vice President and Head of Strategic Corporate Development, Bristol-Myers SquibbStephen Sands, Vice Chairman Investment Banking and Chairman Global Healthcare Group, LazardRajeev Shah, Managing Director & Portfolio Manager, RA CapitalNathan Tinker, PhD, Executive Director, NewYorkBIO

#BIOCEO17 3

BENEFITS BREAKDOWN

Melissa Arndorfer: marndorfer@bio.org, 202-962-9512

Contact us today!

Price (USD)Number of

Registrations

Recognition on Conference

Website and Marketing Materials

Advertisement throughout Conference

Materials and/or Signage

Acces to BIO One-on-One Partnering

Partnering Suite and

Priority Scheduling of Meetings

Guaranteed Speaking

Opportunity

PROGRAM SPONSORSHIP

Participate on “Fireside Chat” 30,000 3 ✔ ✔ ✔ ✔ ✔

Participate on a Panel 25,000 3 ✔ ✔ ✔ ✔ ✔

Company Presentations Sponsor 25,000 3 ✔ ✔ ✔ ✔

NETWORKING OPPORTUNITIES

Welcome Reception Sponsor ** 20,000 2 ✔ ✔ ✔

Breakfast, Lunch and Break Sponsor 15,000 2 ✔ ✔ ✔

Closing Reception Sponsor ** 12,500 2 ✔ ✔ ✔

Tabletop Exhibit (6 available) 12,500 2 ✔ ✔ ✔

PARTNERING AND SOCIAL MEDIA

One-on-One Partnering System Sponsor 25,000 3 ✔ ✔ ✔ ✔

Hospitality Lounge Sponsor 20,000 2 ✔ ✔ ✔ ✔

Partnering Suite Package* TBD 2 ✔ ✔ ✔ ✔

Buzz of BIO Contest Sponsor 15,000 2 ✔ ✔ ✔

Social Media Sponsor 12,500 2 ✔ ✔ ✔

PROMOTIONAL OPPORTUNITIES

Conference Program Sponsor 15,000 2 ✔ ✔ ✔

Conference Bag Sponsor 15,000 2 ✔ ✔ ✔

Lanyard Sponsor 15,000 2 ✔ ✔ ✔

“Digital Daily” Sponsor 12,500 2 ✔ ✔ ✔

WiFi Sponsor 12,500 2 ✔ ✔ ✔

Room Drop Sponsor 12,500 2 ✔ ✔ ✔

Charging Stations Sponsor 7,500 1 ✔ ✔

Luggage/Coat Check Sponsor 7,500 1 ✔ ✔

Hotel Room Key Sponsor 7,500 1 ✔ ✔

Branding Package 6,500 0 ✔ ✔

ADVERTISING OPPORTUNITIES

Conference Bag Insert 2,500 0 ✔

Conference Program Advertisement 2,500 0 ✔

Benefits

* Subject to availability. Please contact marndorfer@bio.org for details.** Extra tickets for guests available.

Sponsorship Package

bio.org/CEO

February 13-14, 2017 • The Waldorf Astoria New York

CEO INVESTORCONFERENCE

4

2017 SPONSORS

Double Helix Sponsors

Conference Sponsors

Media Partners

Regional Partners

Local Co-Host Supporting Bank Sponsors

Haynes and Boone, LLP logosize: 2.5”(width)

C32 M100 Y86 K48

B g3B o